Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II Trials-Reference-Cited by-同舟云学术

Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II Trials

Published:2014-02-14 Issue:2 Volume:9 Page:e82694
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mason James M.,Thomas Kim S.,Crook Angela M.,Foster Katharine A.,Chalmers Joanne R.,Nunn Andrew J.,Williams Hywel C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up;NH Cox;British Journal of Dermatology,2006

2. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation;A Jeng;Medicine,2010

3. Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol;P Bernard,1989

4. Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care;N Levell;British Journal of Dermatology,2011

5. Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis;JK Soo;British Journal of Dermatology,2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of first- and second-line antibiotics for cellulitis and erysipelas: a network meta-analysis of randomized controlled trials;Archives of Dermatological Research;2024-09-06

2. Demonstrating the benefit of a cellulitis-specific patient reported outcome measure (CELLUPROM©) as part of the National Cellulitis Improvement Programme in Wales;Journal of Patient-Reported Outcomes;2024-07-10

3. Bacterial Infections;Rook's Textbook of Dermatology;2024-03-19

4. The Impact of Monthly Prophylactic Antibiotics Use in Patients with Recurrent Cellulitis: A 20-Year Population-Based Cohort Study in a Medical Center;Infection and Drug Resistance;2023-06

5. Modalities of group A streptococcal prevention and treatment and their economic justification;npj Vaccines;2023-04-22